1 H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.

Ube3a loss of function alters bioenergy-related metabolism in the AS brain during embryonic development. Furthermore, these neurochemical changes could be linked to the mitochondrial reactive oxygen species and oxidative stress that occurs during the AS embryonic development.